The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

Biocon has launched a ₹4,500 crore Qualified Institutional Placement, setting the floor price at ₹340.20 per share. Proceeds ...

Bengaluru-based Biocon Ltd. closes the window to list its arm, Biocon Biologics Ltd., as it raises Rs 4,500 crore to provide ...

Biocon shares will be in focus of stock market investors on Tuesday, 17 June 2025, after the company's board of directors ...

Biocon, Cipla, Dr Reddy’s, Other Pharma Stocks In Red Amid Trump Tariff Uncertainty; What Should Investors Do?

Biocon launches Rs 4,500-crore QIP to raise funds for debt repayment, Biocon Biologics investment, and corporate needs ...

The company has set the floor price for the issue at Rs 340.20 per equity share, in line with the pricing formula prescribed ...

Kiran Mazumdar-Shaw led global bio-pharmaceutical firm Biocon Ltd plans to launch its proposed QIP (qualified institutional ...

Shares of Biocon Ltd., surged 1.3% on Tuesday after the company's board of directors approved the floor price for the share ...

Biocon Ltd, a global bio-pharmaceutical firm, plans to launch a qualified institutional placement (QIP) soon to raise up to ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

The floor price for the issue has been set at ₹340.20 per share, in line with the pricing formula prescribed by SEBI ...